CYTOSORBENTS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
CYTOSORBENTS CORPORATION (CTSO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 626.00 thousand shares for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-13.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2015-08-13
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2015-06-30 was 615.00K shares, a 44.09% decline year-over-year.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2015-03-31 was 11.00K shares, a 99.93% decline year-over-year.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2014-12-31 was -15.40M shares.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2014-09-30 was 360.00K shares.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2014 was 732.80K shares, a 30.15% increase from fiscal 2013.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2013 was 563.04K shares, a 71.39% decline from fiscal 2012.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2012 was 1.97M shares, a 578.62% increase from fiscal 2011.
- CYTOSORBENTS CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2011 was 290.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month as first filed |
|---|---|---|---|---|---|
| 2015-06-30 | 615.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | 626.00K shares 10-Q · filed 2015-08-13 | -14.78M shares derived: sum of 3 quarters · filed 2015-08-13 | -14.42M shares derived: sum of 4 quarters · filed 2015-08-13 | |
| 2015-03-31 | 11.00K shares 10-Q · filed 2015-05-11 | -15.39M shares derived: sum of 2 quarters · filed 2015-05-11 | -15.03M shares derived: sum of 3 quarters · filed 2015-05-11 | -13.93M shares derived: sum of 4 quarters · filed 2015-05-11 | |
| 2014-12-31 | -15.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -15.04M shares derived: sum of 2 quarters · filed 2015-03-31 | -13.94M shares derived: sum of 3 quarters · filed 2015-03-31 | 732.80K shares 10-K · filed 2015-03-31 | |
| 2014-09-30 | 360.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | 1.46M shares derived: sum of 2 quarters · filed 2014-11-12 | 16.14M shares 10-Q · filed 2014-11-12 | 2.71M shares derived: sum of 4 quarters · filed 2015-03-31 | |
| 2014-06-30 | 1.10M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | 15.78M shares 10-Q · filed 2014-08-12 | 2.35M shares derived: sum of 3 quarters · filed 2015-03-31 | 2.35M shares derived: sum of 4 quarters · filed 2015-03-31 | |
| 2014-03-31 | 14.68M shares 10-Q · filed 2014-05-14 | 1.25M shares derived: sum of 2 quarters · filed 2015-03-31 | 1.25M shares derived: sum of 3 quarters · filed 2015-03-31 | 13.31M shares derived: sum of 4 quarters · filed 2015-03-31 | |
| 2013-12-31 | -13.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -13.42M shares derived: sum of 2 quarters · filed 2015-03-31 | -1.37M shares derived: sum of 3 quarters · filed 2015-03-31 | 563.04K shares 10-K · filed 2015-03-31 | 14.08M shares 10-K · filed 2014-03-31 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | 12.05M shares derived: sum of 2 quarters · filed 2013-11-06 | 13.98M shares 10-Q · filed 2013-11-06 | 13.98M shares derived: sum of 4 quarters · filed 2014-03-31 | |
| 2013-06-30 | 12.05M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | 13.98M shares 10-Q · filed 2013-08-14 | 13.98M shares derived: sum of 3 quarters · filed 2014-03-31 | 15.09M shares derived: sum of 4 quarters · filed 2014-03-31 | |
| 2013-03-31 | 1.93M shares 10-Q · filed 2013-05-15 | 1.93M shares derived: sum of 2 quarters · filed 2014-03-31 | 3.03M shares derived: sum of 3 quarters · filed 2014-03-31 | ||
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | 1.10M shares derived: sum of 2 quarters · filed 2014-03-31 | 1.97M shares 10-K · filed 2014-03-31 | ||
| 2012-09-30 | 1.10M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-21 | 1.97M shares 10-Q · filed 2012-11-21 | |||
| 2012-06-30 | 868.00K shares 10-Q · filed 2012-08-13 | ||||
| 2011-12-31 | 290.00K shares 10-K · filed 2013-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |